The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Heparin coatings for improving blood compatibility of medical devices
Open accessAbstract
Blood contact with biomaterials triggers activation of multiple reactive mechanisms that can impair the performance of implantable medical devices and potentially cause serious adverse clinical events. This includes thrombosis and thromboembolic complications due to activation of platelets and the coagulation cascade, activation of the complement system, and inflammation. Numerous surface coatings have been developed to improve blood compatibility of biomaterials. For more than thirty years, the anticoagulant drug heparin has been employed as a covalently immobilized surface coating on a variety of medical devices. This review describes the fundamental principles of non-eluting heparin coatings, mechanisms of action, and clinical applications with focus on those technologies which have been commercialized. Because of its extensive publication history, there is emphasis on the CARMEDA ® BioActive Surface (CBAS ® Heparin Surface), a widely used commercialized technology for the covalent bonding of heparin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schömig, A., Neumann, F.-J., Kastrati, A., Schühlen, H., Blasini, R., Hadamitzky, M., Walter, H., Zitzmann-Roth, E.-M., Richardt, G., Alt, E., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604253341702 · Cited by 2,028
Intracoronary Stenting Without Anticoagulation Accomplished With Intravascular Ultrasound Guidance
Colombo, A., Hall, P., Nakamura, S., Almagor, Y., Maiello, L., Martini, G., Gaglione, A., Goldberg, S. L., & Tobis, J. M. (1995) · Circulation · doi:10.1161/01.cir.91.6.1676 · Cited by 1,428
Gorbet, M. B., & Sefton, M. V. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2004.01.023 · Cited by 1,347
Temporal Aspects of Heparin-Induced Thrombocytopenia
Warkentin, T. E., & Kelton, J. G. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104263441704 · Cited by 977
Encyclopedia of Biomaterials and Biomedical Engineering
(2008) · CRC Press eBooks · doi:10.1201/9780429154065 · Cited by 700
Bertrand, M. E., Legrand, V., Boland, J., Fleck, E., Bonnier, J., Emmanuelson, H., Vrolix, M., Missault, L., Chierchia, S., Casaccia, M., et al. (1998) · Circulation · doi:10.1161/01.cir.98.16.1597 · Cited by 583
Medical device‐induced thrombosis: what causes it and how can we prevent it?
Jaffer, I. H., Fredenburgh, J. C., Hirsh, J., & Weitz, J. I. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12961 · Cited by 557
The separation of active and inactive forms of heparin
Lam, L. H., Silbert, J. E., & Rosenberg, R. D. (1976) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(76)90558-1 · Cited by 492
Delayed-Onset Heparin-Induced Thrombocytopenia and Thrombosis
Warkentin, T. E., & Kelton, J. G. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-7-200110020-00009 · Cited by 467
Heparin Bonding on Colloidal Graphite Surfaces
Gott, V. L., Whiffen, J. D., & Dutton, R. C. (1963) · Science · doi:10.1126/science.142.3597.1297 · Cited by 457
Andersson, L.-O., Barrowcliffe, T. W., Holmer, E., Johnson, E. A., & Sims, G. E. C. (1976) · Thrombosis Research · doi:10.1016/0049-3848(76)90105-5 · Cited by 457
Further characterization of the antithrombin-binding sequence in heparin
Thunberg, L., Bäckström, G., & Lindahl, U. (1982) · Carbohydrate Research · doi:10.1016/s0008-6215(00)81050-2 · Cited by 455
Larm, O., Larsson, R., & Olsson, P. (1983) · Biomaterials, Medical Devices, and Artificial Organs · doi:10.3109/10731198309118804 · Cited by 437
The role of complement in biomaterial-induced inflammation
Nilsson, B., Ekdahl, K. N., Mollnes, T. E., & Lambris, J. D. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2006.06.020 · Cited by 431
Höök, M., Björk, I., Hopwood, J., & Lindahl, U. (1976) · FEBS Letters · doi:10.1016/0014-5793(76)80592-3 · Cited by 423
Glycosaminoglycans and the regulation of blood coagulation
Bourin, M. C., & Lindahl, U. (1993) · Biochemical Journal · doi:10.1042/bj2890313 · Cited by 419
Wendel, H. (1999) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/s1010-7940(99)00210-9 · Cited by 277
Kinetics of intravenously administered heparin in normal humans
de Swart, C., Nijmeyer, B., Roelofs, J., & Sixma, J. (1982) · Blood · doi:10.1182/blood.v60.6.1251.1251 · Cited by 253
Petitou, M. (2003) · Biochimie · doi:10.1016/s0300-9084(03)00078-6 · Cited by 241
Blockmans, D., Deckmyn, H., & Vermylen, J. (1995) · Blood Reviews · doi:10.1016/0268-960x(95)90020-9 · Cited by 241
Holmer, E., Kurachi, K., & Söderström, G. (1981) · Biochemical Journal · doi:10.1042/bj1930395 · Cited by 239
de Agostini, A. I., Watkins, S. C., Slayter, H. S., Youssoufian, H., & Rosenberg, R. D. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.3.1293 · Cited by 239
Incorporation of heparin into biomaterials
Sakiyama-Elbert, S. E. (2014) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.08.045 · Cited by 222
Heparin-Binding Domains in Vascular Biology
Muñoz, E. M., & Linhardt, R. J. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000137189.22999.3f · Cited by 212
Immobilization of Heparin: Approaches and Applications
Linhardt, R., Murugesan, S., & Xie, J. (2008) · Current Topics in Medicinal Chemistry · doi:10.2174/156802608783378891 · Cited by 202
Biocompatibility aspects of new stent technology
Bertrand, O. F., Sipehia, R., Mongrain, R., Rodés, J., Tardif, J.-C., Bilodeau, L., Côté, G., & Bourassa, M. G. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00289-7 · Cited by 201
Begovac, P. C., Thomson, R. C., Fisher, J. L., Hughson, A., & Gällhagen, A. (2003) · European Journal of Vascular and Endovascular Surgery · doi:10.1053/ejvs.2002.1909 · Cited by 198
Purification and characterization of bovine tissue factor.
Bach, R., Nemerson, Y., & Konigsberg, W. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68847-2 · Cited by 193
Hårdhammar, P. A., van Beusekom, H. M. M., Emanuelsson, H. U., Hofma, S. H., Albertsson, P. A., Verdouw, P. D., Boersma, E., Serruys, P. W., & van der Giessen, W. J. (1996) · Circulation · doi:10.1161/01.cir.93.3.423 · Cited by 187
Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass
Fosse, E., Moen, O., Johnson, E., Semb, G., Brockmeier, V., Mollnes, T. E., Fagerhol, M. K., & Venge, P. (1994) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(94)92231-4 · Cited by 162
Hemocompatibility of heparin-coated surfaces and the role of selective plasma protein adsorption
Weber, N., Wendel, H. P., & Ziemer, G. (2002) · Biomaterials · doi:10.1016/s0142-9612(01)00122-3 · Cited by 162
The Elimination from Plasma of Intravenous Heparin An Experimental Study on Dogs and Humans
Olsson, P., Lagergren, H., & Ek, S. (1963) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1963.tb17446.x · Cited by 147
Frequency of Heparin-Induced Thrombocytopenia
Lee, D. H. (2003) · Informa Healthcare eBooks · doi:10.1201/9780203027363.ch4 · Cited by 138
Heparin kinetics determined by three assay methods
Bjornsson, T. D., Wolfram, K. M., & Kitchell, B. B. (1982) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1982.16 · Cited by 136
Lin, P. H., Chen, C., Bush, R. L., Yao, Q. C., Lumsden, A. B., & Hanson, S. R. (2004) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2004.01.046 · Cited by 135
Vascular sequestration of heparin
Mahadoo, J., Hiebert, L. M., & Jaques, L. B. (1978) · Thrombosis Research · doi:10.1016/0049-3848(78)90087-7 · Cited by 126
Biocompatibility of extracorporeal circulation
Videm, V., Mollnes, T. E., Garred, P., & Svennevig, J. L. (1991) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)36696-6 · Cited by 124
Lindholt, J. S., Gottschalksen, B., Johannesen, N., Dueholm, D., Ravn, H., Christensen, E. D., Viddal, B., Flørenes, T. L., Pedersen, G., Rasmussen, M., et al. (2011) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2011.01.021 · Cited by 122
On the influence of flow conditions and wettability on blood material interactions
Spijker, H. S., Graaff, R., Boonstra, P. W., Busscher, H. J., & van Oeveren, W. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00380-6 · Cited by 119
The temporal profile of the anti-PF4/heparin immune response
Greinacher, A., Kohlmann, T., Strobel, U., Sheppard, J. I., & Warkentin, T. E. (2008) · Blood · doi:10.1182/blood-2008-08-173062 · Cited by 115
Catabolism of low-dose heparin in man
Dawes, J., & Pepper, D. S. (1979) · Thrombosis Research · doi:10.1016/0049-3848(79)90004-5 · Cited by 113
Daenens, K., Schepers, S., Fourneau, I., Houthoofd, S., & Nevelsteen, A. (2009) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2008.12.009 · Cited by 108
Contact Activation: A Revision
Schmaier, A. H. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657509 · Cited by 103
Andersson, J., Sánchez, J., Ekdahl, K. N., Elgue, G., Nilsson, B., & Larsson, R. (2003) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.10104 · Cited by 98
Studies of Adsorption, Activation, and Inhibition of Factor XII on Immobilized Heparin
Sánchez, J., Elgue, G., Riesenfeld, J., et al. (1998) · Thrombosis Research · doi:10.1016/s0049-3848(97)00310-1 · Cited by 96
Heparin-coated Wiktor stents in human coronary arteries (MENTOR Trial)
Vrolix, M., Legrand, V. M. G., Reiber, J. H. C., Grollier, G., Schalij, M. J., Brunel, P., Elbal, L. M., Gómez-Recio, M., Bär, F. W. H. M., Bertrand, M. E., et al. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)00951-6 · Cited by 92
Bioactive technologies for hemocompatibility
Tanzi, M. C. (2005) · Expert Review of Medical Devices · doi:10.1586/17434440.2.4.473 · Cited by 91
Fukutomi, M., Kobayashi, S., Niwaya, K., Hamada, Y., & Kitamura, S. (1996) · Artificial Organs · doi:10.1111/j.1525-1594.1996.tb04538.x · Cited by 78
Wöhrle, J. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2608 · Cited by 78
Heparin surfaces: Impact of immobilization chemistry on hemocompatibility and protein adsorption
Gore, S., Andersson, J., Biran, R., Underwood, C. J., & Riesenfeld, J. (2014) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.33154 · Cited by 76
Self-citationHeparin‐Coated Equipment Reduces Complement Activation during Cardiopulmonary Bypass in the Pig
Nilsson, L., Storm, K., Thelin, S., Bagge, L., Hultman, J., Thorelius, J., & Nilsson, U. (1990) · Artificial Organs · doi:10.1111/j.1525-1594.1990.tb01591.x · Cited by 75
Johnell, M., Elgue, G., Larsson, R. L., Larsson, A., Thelin, S., & Siegbahn, A. (2002) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2002.122551 · Cited by 72
Lin, P. H., Bush, R. L., Yao, Q. C., Lumsden, A. B., & Chen, C. (2004) · Journal of Surgical Research · doi:10.1016/j.jss.2003.12.026 · Cited by 67
On the Mechanism of Coagulation Inhibition on Surfaces with End Point Immobilized Heparin
Elgue, G., Blombäck, M., Olsson, P., & Riesenfeld, J. (1993) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649568 · Cited by 59
Mollnes, T. E., Riesenfeld, J., Garred, P., Nordström, E., Högåsen, K., Fosse, E. T., Götze, O., & Harboe, M. (1995) · Artificial Organs · doi:10.1111/j.1525-1594.1995.tb02450.x · Cited by 58
Kopp, R., Mottaghy, K., & Kirschfink, M. (2002) · ASAIO Journal · doi:10.1097/00002480-200211000-00005 · Cited by 57
Biocompatibility of Heparin‐Coated Extracorporeal Bypass Circuits: New Heparin Bonded Bioline System
Tayama, E., Hayashida, N., Akasu, K., Kosuga, T., Fukunaga, S., Akashi, H., Kawara, T., & Aoyagi, S. (2000) · Artificial Organs · doi:10.1046/j.1525-1594.2000.06615.x · Cited by 55
Nilsson, U., Larm, O., Nilsson, B., Storm, K., Elwing, H. B., & EKDAHL, K. N. (1993) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1993.tb02564.x · Cited by 52
Kocsis, J. F., Llanos, G. R., & Holmer, E. (2000) · Journal of Long-Term Effects of Medical Implants · doi:10.1615/jlongtermeffmedimplants.v10.i12.50 · Cited by 50
Koster, A., Sänger, S., Hansen, R., Sodian, R., Mertzlufft, F., Harke, C., Kuppe, H., Hetzer, R., & Loebe, M. M. (2000) · ASAIO Journal · doi:10.1097/00002480-200005000-00015 · Cited by 44
S�nchez, J., Elgue, G., Riesenfeld, J., & Olsson, P. (1997) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(199710)37:1<37::aid-jbm5>3.0.co;2-k · Cited by 44
Heparin antibodies and thromboembolism in heparin-coated and noncoated ventricular assist devices
Koster, A., Loebe, M. M., Sodian, R., Potapov, E. V., Hansen, R., Müller, J., Mertzlufft, F., Crystal, G. J., Kuppe, H., & Hetzer, R. (2001) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2001.111655 · Cited by 44
Blezer, R., Cahalan, L., Cahalan, P. T., & Lindhout, T. (1998) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-199807000-00006 · Cited by 40
Haemocompatibility of paediatric membrane oxygenators with heparin-coated surfaces
Wendel, H. P., Scheule, A. M., Eckstein, F. S., & Ziemer, G. (1999) · Perfusion · doi:10.1177/026765919901400104 · Cited by 39
COMPLEMENT ACTIVATION AND BIOINCOMPATIBIUTY
Mollnes, T. E., Videm, V., Riesenfeld, J., Garred, P., Svennevig, J. L., Fosse, E. T., Högåsen, K., & Harboe, M. (1991) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1991.tb06202.x · Cited by 36
Binding of antithrombin to immobilized heparin under varying flow conditions.
Pasche, B., Elgue, G., Olsson, P., Riesenfeld, J., & Rasmuson, A. (1991) · PubMed · Cited by 34
Antithrombin activity of surface‐bound heparin studied under flow conditions
Lindhout, T., Blezer, R., Schoen, P., Willems, G. M., Fouache, B., Verhoeven, M., Hendriks, M., Cahalan, L., & Cahalan, P. T. (1995) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820291013 · Cited by 33
Cornelius, R. M., Sánchez, J., Olsson, P., & Brash, J. L. (2003) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.10118 · Cited by 33
Platelet Compatibility of an Artificial Surface Modified with Functionally Active Heparin
Videm, V., Christiansen, D., Bergseth, G., et al. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614342 · Cited by 30
Plötz, F. B., van Oeveren, W., Hultquist, K. A., Miller, C. G., Bartlett, R. H., & Wildevuur, C. R. H. (1992) · Artificial Organs · doi:10.1111/j.1525-1594.1992.tb00533.x · Cited by 27
Stammers, A. H., Christensen, K. A., Lynch, J. C., Zavadil, D. P., Deptula, J. J., & Sydzyik, R. T. (1999) · Journal of ExtraCorporeal Technology · doi:10.1051/ject/1999313135 · Cited by 25
Høgevold, H. E., Moen, O., Fosse, E. T., Venge, P., Bråten, J., Andersson, C., & Lyberg, T. (1997) · Perfusion · doi:10.1177/026765919701200103 · Cited by 21
Heparin Binding to Improve Biocompatibility
(2008) · CRC Press eBooks · doi:10.1081/e-ebbe2-120007312 · Cited by 11
Thromboresistant Vascular Graft
Begovac, P. C., Pond, D., Recknor, J. B., & Scholander, E. (2015) · Wiley eBooks · doi:10.1002/9781119002956.ch06 · Cited by 3
Self-citationCapila, I., & Linhardt, R. J. (2002) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20020201)41:3<390::aid-anie390>3.0.co;2-b
Cited by
Osman, A. I., Chen, Z., Elgarahy, A. M., Farghali, M., Mohamed, I. M. A., Priya, A. K., Hawash, H. B., & Yap, P. (2024) · Advanced Energy and Sustainability Research · doi:10.1002/aesr.202400011 · Cited by 365
Metadata
- Authors
- Biran, R., & Pond, D.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2017-03
- Volume
- 112
- Pages
- 12-23
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2563390568
- Cited by
- 334
- References
- 75
- FWCI
- 0.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.